United States
Germany
Japan
United Kingdom
China
Carrier-free (BSA/glycerol-free) SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI2E3
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Antibodies
Carrier-free (BSA/glycerol-free) SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI1B8
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Carrier-free (BSA/glycerol-free) SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI6F10
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Carrier-free (BSA/glycerol-free) SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI1E9
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
Carrier-free (BSA/glycerol-free) SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI4F4
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 N Protein Mouse Monoclonal Antibody, Clone OTI3E1
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI4C6
| Applications | ELISA, WB |
| Reactivities | SARS-CoV-2 |
SARS-Cov-2 N protein mouse monoclonal antibody, clone OTI1E9
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI4G5
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI2E3
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI4F4
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI1D3
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI6G7
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI12G4
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 spike protein mouse monoclonal antibody, clone OTI7F6
| Applications | ELISA |
| Reactivities | SARS-CoV-2 |
